Brief: Glycorex Transplantation granted funds from Vinnova
Dec 10 (Reuters) - Glycorex Transplantation publ AB GTABb.NGM :
* Has been granted funds from Vinnova, a total of 4.3 million Swedish crowns over two years,
for developing a product for treatment of Myasthenia gravis
Source text for Eikon: ID:nNGn4RMbHg
Further company coverage: GTABb.NGM
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))